Ophthalmic Acid: A Breakthrough May Reverse Parkinson’s Movement Deficits

New discovery reveals ophthalmic acid as a potential therapeutic target for Parkinson’s and other movement disorders, surpassing the effects of L-dopa.

Oct 05, 2024

∙ Paid

A scientific illustration showing the brain and a highlighted pathway of ophthalmic acid influencing motor function, representing the connection to Parkinson's disease. The image should include neurons, receptors, and a visual comparison between dopamine and ophthalmic acid. Subtle elements such as improved movement (e.g., a silhouette walking or moving freely) should be included to convey the reversal of Parkinson’s symptoms. The background should feature calming, medical tones to indicate research and innovation.

Topline:

Researchers from the University of California, Irvine, have uncovered that a brain molecule, ophthalmic acid, mimics dopamine in improving motor function in Parkinson’s disease models. This discovery could lead to groundbreaking new treatments for movement disorders, offering a longer-lasting alternative to L-dopa.

Study Details:
Parkinson’s dise…

Keep reading with a 7-day free trial

Subscribe to Just Healthcare to keep reading this post and get 7 days of free access to the full post archives.